Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02134847 · ClinicalTrials.gov registry record · NA

Multi-center Clinical Trial of Limiting Resident Work Hours on ICU Patient Safety

A NA study, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
413
Enrollment target

NCT02134847: Completed NA study, sponsored by Brigham and Women's Hospital.

NCT02134847 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 413 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02134847, a NA study, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
413 participants
Enrollment target

Study Summary

In this proposal, we seek to address conclusively two knowledge gaps: 1) the lack of data on the relationship between PGY2+ (post graduate year 2) sleep deprivation and patient safety; and 2) the lack of data on the relationship between resident sleep deprivation and preventable patient injuries. Through the Clinical and Translational Science Award (CTSA)-funded Sleep Research Network, the largest and only federally-funded sleep science network in the U.S., we propose conducting a multi-center randomized crossover trial in six pediatric ICUs staffed by PGY2 and PGY3 residents. We will compare rates of all serious errors (i.e., rates of harmful and other serious medical errors due to any cause, including but not limited to fatigue-related errors, handoff errors, and provider knowledge deficits) of a sleep and circadian science-based (SCS) intervention schedule with a traditional schedule that includes frequent shifts of 24 hours or longer. Our specific aims will be: 1. To test the hypothesis that PGY2\&3 residents working on an SCS intervention schedule will make significantly fewer harmful medical errors (preventable adverse events) and other serious medical errors (near misses) while caring for ICU patients than residents working on a traditional schedule; (primary endpoints: resident-related preventable adverse events and near misses) 2. To test the hypothesis that rates of harmful medical errors (preventable adverse events) and other serious medical errors (near misses) throughout the ICU (i.e., those involving and those not involving residents) will be lower in ICUs when PGY2\&3 residents work on an SCS intervention schedule than when residents work on a traditional schedule; (major secondary endpoints: ICU-wide preventable adverse events and near misses) 3. To test the hypothesis that resident physicians' risk of neurobehavioral performance failures and motor vehicle crashes - as assessed through simple visual reaction time tasks \[Johns Drowsiness Score (JDS)

Primary Outcome

PGY2\&3 residents working on an SCS intervention schedule will make significantly fewer harmful medical errors (preventable adverse events) and other serious medical errors (near misses) while caring for ICU patients than residents working on a traditional schedule;(primary endpoints: resident-related preventable adverse events and near misses)

Interventions

  • OTHER SCS intervention schedule

Trial Details

FieldValue
Enrollment Target 413 participants
Start Date 2013-07-01
Est. Completion 2017-03-05
Phase NA
Brigham and Women's Hospital

937 total trials

What the finished NCT02134847 record still lists

NCT02134847 is an interventional study that assigns participants to a tested intervention. The registered 413 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).

The record links to 0 conditions, and to 1 intervention - of which SCS intervention schedule is the first listed.

NCT02134847 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02134847 about?

NCT02134847 is a clinical study titled "Multi-center Clinical Trial of Limiting Resident Work Hours on ICU Patient Safety". In this proposal, we seek to address conclusively two knowledge gaps: 1) the lack of data on the relationship between PGY2+ (post graduate year 2) sleep deprivation and patient safety; and 2) the lack of data on the relationship between resident sleep deprivation and preventable patient injuries. Th...

What is the current status of trial NCT02134847?

This trial is currently completed. It is a NA study. The enrollment target is 413 participants. The study started on 2013-07-01. Estimated completion is 2017-03-05.

What interventions are being tested in trial NCT02134847?

The interventions under investigation include: SCS intervention schedule (OTHER).

Who is sponsoring clinical trial NCT02134847?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02134847's enrollment target sits among peer trials

413 241st of 2000 higher than 1,760 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03592472 · 413 participants · Phase 3

    A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)

  • NCT06697197 · 413 participants · Phase 1

    A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors

  • NCT04776941 · 414 participants · NA

    Expressive Writing for the Management of Stress in Cancer Survivors

  • NCT06792552 · 414 participants · Phase 1

    A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02134847, the US trial registry maintained by the National Library of Medicine. NCT02134847 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.